Phoenix Labs
Manufacturing · Ireland · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Bunkilla Plz Ste 12, Clonee, An Mhi, Ire...Phone Number
+353 14688900Website
www.phoenixlabs.ieRevenue
$7.5 MillionIndustry
About Phoenix Labs
Is Phoenix Labs your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Phoenix Labs
Product Launch: Get notified when Phoenix Labs launches new products
Check if Phoenix Labs has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Phoenix Labs has new funding data
Website visits: Recent activity has been detected on your website
Check out if Phoenix Labs is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Phoenix Labs recently announced quarterly report
Click to see if Phoenix Labs had a recent Job posting/layoffs
Phoenix Labs, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Find VP level buyers at Phoenix Labs
Find 3 more new buyers
Company Profile Activity
Activity Insights
Phoenix Labs is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Phoenix Labs is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Phoenix Labs.
Phoenix Labs Tech Stack
A closer look at the technologies used by Phoenix Labs
Top Manufacturing Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding Phoenix Labs
Phoenix Labs was incorporated in June 2000. Since then we have been a leading player in the Irish pharmaceutical market and have expanded through organic growth and through the acquisition of T.P. Whelehan & Co Ltd from Uniphar Plc in October 2010. We are an integrated healthcare company operating in the prescription and OTC market segments. Phoeni... Read More